Hakan Çam

1.4k total citations
28 papers, 1.1k citations indexed

About

Hakan Çam is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hakan Çam has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hakan Çam's work include Virus-based gene therapy research (4 papers), CAR-T cell therapy research (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Hakan Çam is often cited by papers focused on Virus-based gene therapy research (4 papers), CAR-T cell therapy research (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Hakan Çam collaborates with scholars based in United States, Türkiye and Italy. Hakan Çam's co-authors include Peter J. Houghton, John Easton, Anthony A. High, Maren Cam, Ryan D. Roberts, Boris Engels, Wolfgang Uckert, Thomas Blankenstein, Thomas Schüler and Stefano Indraccolo and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and PLoS ONE.

In The Last Decade

Hakan Çam

26 papers receiving 1.1k citations

Peers

Countries citing papers authored by Hakan Çam

Since Specialization

Citations

This map shows the geographic impact of Hakan Çam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakan Çam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakan Çam more than expected).

Fields of papers citing papers by Hakan Çam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hakan Çam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakan Çam. The network helps show where Hakan Çam may publish in the future.

Co-authorship network of co-authors of Hakan Çam

This figure shows the co-authorship network connecting the top 25 collaborators of Hakan Çam. A scholar is included among the top collaborators of Hakan Çam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakan Çam. Hakan Çam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting TGFβ docking receptor glycoprotein A repetitions predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma 2025 ·Neuro-Oncology ·Bill X. Wu, (unknown), Hakan Çam, Chelsea Bolyard, Yuzhou Chang, Jay K. Mandula, P.W. Welsh, (unknown), Anqi Li, (unknown), (unknown), (unknown), J. Bradley Elder, Pierre Giglio, José Javier Otero, Prajwal Rajappa, Damien Gerald, Dongjun Chung, Qin Ma, Maria Velegraki, Zihai Li	1
2	Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood Sarcoma 2023 ·Molecular Cancer Therapeutics ·Terry J. Shackleford, (unknown), Angelina V. Vaseva, (unknown), (unknown), Hemant K. Bid, Fuyang Li, Haihong Zhong, Doris A. Phelps, Ryan D. Roberts, Hakan Çam, Cheryl A. London, Denis C. Guttridge, Yidong Chen, Manjeet K. Rao, Yuzuru Shiio, Peter J. Houghton	5
3	Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence 2022 ·Journal of Hematology & Oncology ·(unknown), Chelsea Bolyard, Bill X. Wu, Hakan Çam, Pierre Giglio, Zihai Li	52
4	Serum hepcidin levels are related to serum markers for iron metabolism and fibrosis stage in patients with chronic hepatitis B: A cross-sectional study 2020 ·Arab Journal of Gastroenterology ·Hakan Çam, (unknown)	7
5	IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis 2018 ·JCI Insight ·Amy C. Gross, Hakan Çam, Doris A. Phelps, Amanda J. Saraf, Hemant K. Bid, Maren Cam, Cheryl A. London, (unknown), Michael Arnold, Laura Brandolini, Xiaokui Mo, John Hinckley, Peter J. Houghton, Ryan D. Roberts	62
6	Study of ideal topical pharyngeal anesthesia in upper gastrointestinal system endoscopy: A double-blind, randomized, controlled trial 2016 ·The Turkish Journal of Gastroenterology ·Hakan Çam, Seda Pehlivan, (unknown), (unknown), (unknown), Murat Gülşen	3
7	Regulation of FANCD2 by the mTOR Pathway Contributes to the Resistance of Cancer Cells to DNA Double-Strand Breaks 2013 ·Cancer Research ·Changxian Shen, (unknown), Doris A. Phelps, Hakan Çam, Christopher E. Pelloski, Qishen Pang, Peter J. Houghton	74
8	ΔNp63 Promotes Pediatric Neuroblastoma and Osteosarcoma by Regulating Tumor Angiogenesis 2013 ·Cancer Research ·Hemant K. Bid, Ryan D. Roberts, Maren Cam, Anthony Audino, Raushan T. Kurmasheva, Jiayuh Lin, Peter J. Houghton, Hakan Çam	47
9	Peginterferon alfa related psoriasis in a patient with acute hepatitis C and review of the literature 2013 ·Wiener klinische Wochenschrift ·(unknown), Zeynel Abidin Öztürk, (unknown), Hakan Çam, Abdurrahman Kadayıfçı	2
10	p53/TAp63 and AKT Regulate Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling through Two Independent Parallel Pathways in the Presence of DNA Damage 2013 ·Journal of Biological Chemistry ·Maren Cam, Hemant K. Bid, Linlin Xiao, Gerard P. Zambetti, Peter J. Houghton, Hakan Çam	47
11	Effects of probiotics on methionine cholinedeficient diet-induced steatohepatitis in rats 2012 ·The Turkish Journal of Gastroenterology ·Nermin Karahan, Mehmet İşler, Ahmet Koyu, Aynur Gül Karahan, (unknown), İbrahim Metin Çiriş, Recep Sütçü, (unknown), Hakan Çam, (unknown)	19
12	Regulation of mammalian target of rapamycin complex 1 (mTORC1) by hypoxia: causes and consequences 2011 ·Targeted Oncology ·Hakan Çam, Peter J. Houghton	19
13	Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting 2011 ·European Journal of Clinical Pharmacology ·Osman Gökalp, Arzu Gunes, Hakan Çam, Erkan Cüre, Osman Aydın, Mehmet Numan Tamer, Maria Gabriella Scordo, Marja‐Liisa Dahl	26
14	mTORC1 Signaling under Hypoxic Conditions Is Controlled by ATM-Dependent Phosphorylation of HIF-1α 2010 ·Molecular Cell ·Hakan Çam, John Easton, Anthony A. High, Peter J. Houghton	212
15	Recurrent Gastrointestinal Bleeding in a Patient with Eisenmenger Syndrome Using Bosentan 2010 ·Current Drug Safety ·İbrahim Sarı, Hakan Çam, (unknown), Erdal Durmuş, Tarık Kıvrak, Kürşat Tigen, Vedat Davutoğlu	0
16	Caffeic acid phenethyl ester modulates methotrexate-induced oxidative stress in testes of rat 2008 ·Human & Experimental Toxicology ·A. Armağan, (unknown), Efkan Uz, (unknown), Süleyman Kutluhan, (unknown), Sedat Soyupek, Hakan Çam, (unknown)	71
17	p53 family members in myogenic differentiation and rhabdomyosarcoma development 2006 ·Cancer Cell ·Hakan Çam, Heidi Griesmann, Michaela Beitzinger, Lars Hofmann, Rasa Beinoravičiūtė-Kellner, Markus Sauer, (unknown), (unknown), Peter Friedl, Stefan Gattenlöhner, Małgorzata Burek, Andreas Rosenwald, Thorsten Stiewe	91
18	Protective role of erdosteine on vancomycin-induced oxidative stress in rat liver 2006 ·Molecular and Cellular Biochemistry ·Mehmet Şahin, Hakan Çam, Şeref Olgar, Şevket Ercan Tunç, Çağatay Arslan, Efkan Uz, H. Ramazan Yılmaz	24
19	Osteosclerosis due to endemic fluorosis 2006 ·The Science of The Total Environment ·Mehmet Numan Tamer, Banu Kale Köroğlu, Çağatay Arslan, M. Volkan Akdoğan, Mert Köroğlu, Hakan Çam, Mustafa Yıldız	54
20	Retroviral Vectors for High-Level Transgene Expression in T Lymphocytes 2003 ·Human Gene Therapy ·Boris Engels, Hakan Çam, Thomas Schüler, Stefano Indraccolo, (unknown), Christopher Baum, Thomas Blankenstein, Wolfgang Uckert	153

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact